









Markets
/
Stocks
/
nasdaq-cmmb
/

Chemomab Therapeutics Ltd

CMMB

View Detailed Chart

1.025USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

19.33MMarket Cap

LossP/E TTM



Chemomab Therapeutics Ltd

1.025

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-3.74%

5 Days

-5.96%

1 Month

-11.64%

6 Months

-51.88%

Year to Date

-43.37%

1 Year

-1.44%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

STRONG BUY

Current Rating

8.500

Target Price

729.27%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Chemomab Therapeutics Ltd

CMMB

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(0)

Buy(0)

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.008

Sell

RSI(14)

22.021

Sell

STOCH(KDJ)(9,3,3)

6.655

Oversold

ATR(14)

0.059

Low Volatility

CCI(14)

-194.190

Sell

Williams %R

97.368

Oversold

TRIX(12,20)

-0.450

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.071

Sell

MA10

1.086

Sell

MA20

1.119

Sell

MA50

1.205

Sell

MA100

1.219

Sell

MA200

1.482

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Ticker SymbolCMMB

CompanyChemomab Therapeutics Ltd

CEODr. Adi Mor, Ph.D.

Websitehttps://www.chemomab.com/